Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-86.29%Return on Assets
VS
Market
Sector
Industry
History
$ 2.29Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information
Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSPERO THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRO - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 62.12M | $ -53.6M | -86.29% |
| 3/31/2025 | $ 77.71M | $ -69.76M | -89.77% |
| 12/31/2024 | $ 110.54M | $ -68.57M | -62.03% |
| 9/30/2024 | $ 135.16M | $ 3.51M | 2.6% |
| 6/30/2024 | $ 149.88M | $ 17.45M | 11.65% |
| 3/31/2024 | $ 167.7M | $ 23.4M | 13.96% |
| 12/31/2023 | $ 182.39M | $ 22.81M | 12.5% |
| 9/30/2023 | $ 107.1M | $ -1.61M | -1.51% |
| 6/30/2023 | $ 98.89M | $ -10.08M | -10.2% |
| 3/31/2023 | $ 112.55M | $ -26.85M | -23.86% |
Key Performance Insights, Last 5 Years
- SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -53.92%.
- Over the past 5 years, SPERO THERAPEUTICS INC's average ROA has been -50.24%.
- The median ROA for SPERO THERAPEUTICS INC during this period was -52.18%
- SPERO THERAPEUTICS INC reached its highest ROA over the past 5 years at 13.96%.
- The lowest ROA recorded by SPERO THERAPEUTICS INC in the same timeframe -178.02%
SPERO THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for SPERO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -84.68M ] / Assets [ $ 157.04M ]
(=) ROA [ -53.92% ] SPRO - Return on Assets, Last 5 years
-178.02%
Minimum
Jun 30, 2022
13.96%
Maximum
Mar 31, 2024
-50.24%
Average
-52.18%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.09% with a standard deviation of 10.64%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.45K |
|---|---|
| min | -33.42% |
| max | 33.98% |
| average | 0.09% |
| median | 1.53% |
| std | 10.64% |